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We have exa mined the bio logic characteri sti cs and im-
m un o log ic properti es o f epiderm al ce ll-derived lympho-
cyte differentiating fa cto r (ELO IF), a lymphocyte differ-
en tiating facto r produ ced by cultured human keratinocytes. 
T he ELO IF w as semipurified by a gel fi ltration procedure. 
Th is facto r, which is di stinct from prostaglandin s, epider-
mal cell-deri ved th ymocyte activating fa cto r (ETAF) , and 
the we ll-kn o wn thymic ho rm ones (thymu lin , th ymopo ie-
tin, and th ymosin (1) did no t exhibit any interl eukin 
(IL)-1 , IL-2, o r IL-3 acti vity. It stro ng ly inhibited in vitro 
A w id e va ri ety o f skin diseases are chara cte ri zed by a ly mphocy te infiltratio n into the dermis :1I1d, in cer-tain patho logic s itu ati o ns, invas ion o f th e epidermis by T cell s " 1. These observati o ns togeth er w ith the stru ctural and antigeni c similarities between kcrat-
inocy tes and th Yl11i c epith elial cells 12'lllJve led to th e concept o f 
the skin fun ctio nin g as a ly mph o id-associated ti ss ue 13J. Such a 
hypo thes is, po intin g to th e epidermal cell - lymph ocy te intera c-
n o ns in no rm al co nditio ns, was furth er suppo rted by the dem-
onstrati on o f immune l11edi ato rs produ ced b y keratinocytes. An 
epidermal cell-d erived thymocyte acti vating fa cto r (ET AF) 
produced by murine and human keratin ocy tes and endo w ed w ith 
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Abbreviatio ns: 
ATx : adult th y mecto mized (micl') 
COil A : concanavalin A 
EC C: epiderm al ce ll culture 
E LD IF: epidermal ce ll-de ri ved lymphocyte diffe rentiating factor 
ETAF: epiderm al cell -deri ved th ymocyte activ~tin g f., eto r 
FCS: fetal calf serum 
FT S: serum th ymic I: \ctor 
H ESS: Hank s' b ~ lan ced s~ l t solution free of C a ' • 
I L: inte rlcukin 
LPS: lipopo lysaccharide 
M D P: murJ lIl yl dipeptide 
MF: m ycos is fun goidcs 
PHA: ph yto hem agglutinin 
TdT : te rminal dcoxynucleo tidc tra n s fc r~sc 
Iympho proliferative responses o f normal m ouse spleen cells 
to phytohemagglutinin , co ncanavalin A, and lipopol ysac-
charid e. This dose-dependent phenomenon w as associated 
with a suppress ion oflL-2 production rather than an y to xic 
effect. It can be concluded that ELOIF, a product o f human 
epiderma l cell s, which displays in vitro T-cell differenti a-
ti o n and reg ulatory activities, could be of m ajor importance 
in vivo in the control o f cutaneous inAal11matory reactions. 
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interl eukin (IL)-l-like ac tivities, ca n po tenti ate o r stimul ate a va-
ri ety o f immune reacti ons 14,51; in additi on to stimulatin g th y-
m ocy te pro liferati on, it enh ances I L-2 produ ction by mitogen-
stimulated ly mphocy tes and di splays fibrobla st-stimubting ac-
ti vity and chem otactic capacities fo r po lym orphonuclear cells 16 ,7]. 
Recentl y it has been sho wn that cocultivation o f lymphocytes 
with epidermal cell s leads to th e ex press io n of an earl y T-cell 
differentiation marker, terminal deoxynucleotide transferase (TdT) 
18 1· 
In prev io us studies on the ro le o f epidermis in T-cell differ-
l'nti ati on , we have repo rted th at supern atants of cultured human 
epiderm al cell s arc able to indu ce membrane modificatio n on 
T-cell precurso rs similar to th ose described fo r th ymi c horm ones 
r91. The so luble f.,c tor respo nsible fo r such an effect w as call ed 
epiderm al cell-derived lymphocy te differentiatin g fa cto r and re-
fen'ed to as ELDIF. This f.,cto r is specifi c fo r epiderm al cells and 
is di fferent from pros ta g landin s, ETA F, and th e th ymi c ho rm ones 
thYlllu lin , th Yl110sin al , and th YI11opoietin 19"1. The present stud y 
was co ndu cted to get further insi ght into th e fun ction al ca pabil-
ities o f ELDIF o n T and B lymphocytes . We repo rt here that 
ELD IF does no t displa y an y IL-I, IL-2, or IL-3 activity and that 
it is responsibl e fo r a po tent suppression o f lymphocy te prolif-
erative responses. These data suggest th at thi s factor ma y have a 
po tential ro le in the regul atio n of cutaneo us inflammato ry reac-
ti ons. 
MATERIALS AND METHODS 
Mice C57 BLl6 mi ce (6-8- weeks-o ld) purchased fro m IFFA 
C REDO (L'Arbes le, France) were used for lymphocyte prolif-
erati on assay and lL-2 assays . C 57 ,l3L16 mice, th ym ecto mized at 
the age o f 8-1 0 w eeks we re used 10-20 days later in th e bioassay 
fo r T-cell differentiatin g acti vity. C 3H / He Orl mi ce (C NRS, 
O rlea ns, France) were used for lL-1 assays. 
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Human Epidermal Tissue Cultures N o rm al hum an epider-
m al cell suspensions wc rc prepared fro m breas t skin rcm oved 
durin g pl as ti c surgery. E pidermis was separated fro m dermis by 
l-h in cubati on at 37°C in trypsin (G ibco) 0.25% in Han ks' bal-
anced soluti on free o f Ca + + (H BSS) (G ibco, G lasgow, U. K .) . 
The epidcrmis was remo ved w ith fin e force ps and placed in 10% 
fetal ca lf serum (FCS) supplementcd w ith HBSS. A ce ll suspcn-
sion was prepared by repea ted pipettin g and agita ti on o f the epi-
derm al sheets. Cell suspensio ns were poo led , fil te red th rough 
ste ril e ga uze, was hed 3 tim es, and suspended in culture m edium . 
This procedure led to a cell suspensio n co mposed o f basa l epi-
de rm al cells (20-25%), kerat inocytes of th e lower n13 lpighian 
layers, a few l11 elanocy tes , Langerhans cells, and relatcd dendriti c 
undetermined cell s, w hi ch accounted fo r 2- 4% of cpiderm al cells 
11 0 1· E piderm al ce ll vi ability w as > 90% as assessed by trypan 
blue dye ex clusion . After seeding, epidcrm al cells (2 X 105 cell s/cm2) 
w ere g rown o n Ty pe I V rabbit sk in co ll agcn-coated culture dishes 
(CE RA D, Lyon, France) in Dulbecco's modifi ed cagle 's m edium 
(G ibco) supplemented w ith 100 U / ml peni cillin , 100 ,ug/ml strep-
to m ycin, 0. 25 ,ug/ml Fungizone, nonessential amino acids (Gibco), 
10 mM H EPES (pH 7.0) and (a) 20% and 10% FCS fo r the first 
and second day of cultu re, res pectively, th en (b) 20% serum 
substitu te Ultroser-G (IBF, France) I11J. C ul tures were m ain-
ta in ed at 37°C in a 5% CO2 humid atm osphere, and th e culture 
m edium was changed every day fo r 2 days and subsequ entl y every 
o ther day. Under th ese conditi o ns, adh erence of basa l keratin o-
cy tes on culture pl ate occurred durin g th e fIrst ho urs o f culture, 
a conAu ent laye r was es tablished w ithin a week, and o nset o f 
stratifI ca tion of epiderm al cells was obtained by day 10 o f culture. 
T he rel ati ve percen tage o f Lange rh ans cells and related indeter-
min atc cell s am o ng to tal cpiderm al cells, as assessed b y DR an-
tigen ex pression , varied fro m 2-4% by day 0 to 0% by day 7. 
Langerhans Cell Depletion of Epidermal Cell Suspension 
Lan gerh ans cells and epidermal indeterminate cells arc the unique 
epiderm al cells ex pressin g in v ivo cl ass II maj o r histOco mpatibility 
complex determinants. Langerhans cell- and in determinate cell-
depleted cpiderm al cell suspensions were o btain ed as described 11 2 1 
by trea tment w ith BL2- anti-HLA-D R m onocl onal antibod y O. 
Brochie r, Inscrm , U80, Lyon, France) at a fin al dilutio n 1 :200 
and rabbit co mpl ement (fin al diluti on 1:1 0). Prev io ll s studies have 
shown th at such a procedure abo li shes the HLA-DR antigen-
medi ated stimul ati on o f allogeneic T cell s [1 3] and the epiderm al 
cell-induced gene ratio n o f hum an all o reacti ve cy to tox ic T cells 
11 2]. . 
Epidermal Cell Culture (ECC) Supernatants Supern atants 
fro m ECC were harves ted every o th er day fro m days 4-26, cen-
trifu ged fo r 10 min at 1500 g, and sto red at - 22°C until use. 
Bioassay for T-Lymphocyte Differentiating Activity Thi s 
assay based o n theta antigen induction o n theta negative spleen 
cells (T-cell precursors) from adult th ymecto mized (ATx) C57BLl6 
mi ce has been ex tensively described elsew here [1 4] . Sixty mi-
cro liters o f seriall y diluted tes t sa mples were in cubated fo r 75 min 
at 37°C w ith 1. 5 x 106 spleen cell s and aziathio prine at 10 /L g/ ml. 
At this concentrat ion, az iathio prine inhibits rosette fo rm ation in 
no rm al mice but no t in ATx mi ce [1 5 1. At th e end of th e in cu-
batio n time, rosettes w ere fo rmed by (:cntrifu gation o f the spleen 
cell s with 12 X 10(' sheep ery throcytes , th en res uspended by 
ro tati o n on a ro ller at low speed (10 rp m ), and counted. In the 
presence of T-cell differenti atin g fac to rs, rosette fo rm ati on w as 
inhibited by aziathioprine at 10 ,ug/ ml. The acti v ity o f the sa mpl es 
was ex pressed as th e highes t dilutio n conferring on spleen cells 
fro Ill ATx mice the susceptibility to aziathio prine inhibition. Since 
this assa y was o ri g in ally described to m easure theta conversion 
by th y mi c ho rm ones r1 6] and FTS (serum th ymi c fa cto r) in par-
ti cul ar [1 71, E LDIF ac ti v ity w ill be re ferred to as FTS-like acti vity. 
Lymphocyte Proliferation Assay Lymphocytes at 5 X 105 
in 0. 11111 of RPM I m edium (supplemented w ith 1% L-g lutamine, 
T H E JOURNAL OF IN V ESTIGAT IVE DERM ATO LOGy 
2% peni cillin-strep to m ycin , andl 0% hea t-iIl ac ti va ted FCS) we re 
cultured in micro plate wells (Falcon II Micro tes t) w ith 0 .1 tnl of 
serial dilutio ns (fin al concentrati o n '= :L ~, ir, .fr, 2~'" 7~ ') o f the 
sa mples (ECC supernatant o r gel filtr atio n fractio n) o r Ult roser~ 
G- containin g medium alo ne and vari ous mitogens: ph y toh el11~ 
agglutinin-M (PI-IA-M), concanavalin A (Con A), and li po p o _ 
lysaccharide (LPS) at a fin al co ncentration o f 20, 5, and I 0 ,ug/ llll , 
respectivel y 11 8]. After a 24-h in cubati o n at 37°C in 5% CO 2 in 
air , 1 ,uC i o f rJI-lith ymidin e (sp act 2 C i/ I11M ) w as added to ea ch 
well , and the pl ates were incubated fo r an additio nal 24 h under 
th e sa m e conditio ns. Vi ability was assessed by try pan blue ex_ 
clusion tes t. Results arc ex pressed either as /::; cpm (cpm in cu ltu re 
w ith mitogen - cpm in culture w ith out mitogt:n) o r as percent 
o f contro l: 
CpIll in culture w ith mi togen and w ith sa m ple 
cpm in culture w ith mi togen and w ith out sa m ple' 
Interleukin 1 Assay Th ym ocy tes (1.5 X 10(') fro m C3 H/ He 
O rl mi ce in 0 .1 ml of RPMI m edium supplemented w ith anti_ 
bio ti cs, 5% hea t-in ac tivated FC S (Flow Labs, Scotland) and 5 X 
10- 5 M 2-mercap roe thano l were cultured w ith 0. 1 ml o f d iluted 
ECC supern atants o r gel filtrati on column frac tio ns in the prcs_ 
ence o r absence o f a submitogeni c concentratio n (1 ,ug/ ml) of 
PI-IA (Welco m c Labs, Beckenh am , E ng land). After 68 h th e cul_ 
tures were pulsed fo r 4 additi onal h with 1 /LC i o fl 31-1]thymidi ne 
(1 C i/mM , C EA , Sacla y, France) . The cells w ere then collec ted 
on g lass fib er fIlters and th e radi oacti vity was determined b y liqu id 
scintill at io n [1 9]. Results arc ex pressed as /::; cpm representin g: 
cpm in stimulated th y m ocyte culture - cpm in un stimul ated 
th ym ocy te cultures. 
Assay for IL-2 Production and Activity 
Prcparalioll oj IL-2-Colllaillillg SlIpcl'llalalll: S pl ~en cells were di-
luted to 10 X 10(' cell s/ml in RPMI medium containin g 1 % 
L-g lutamine, 100 U / ml peni cillin-strepto m ycin , I % H E PES, :> 
X 10- 5 M 2-merca ptoethano l, and 2% heat-inacti va ted FCS (G lbco) 
[1 8 1. Fi ve hundred mi cro liters o f cell s were culti va ted fo r 24 h at 
37°C in a humidified atmosphere o f5 % CO" in air , in th e presence 
o f 5 ,ug o f Con A (Miles Labo rato ri es) and 500 ,ul o f va ri ous 
diluti ons of ECC supern atants o r gel filtrati on fractio ns . C ultures 
(1 ml) were set in Linbro tissu e culture plates w ith 24 Aat-bot tonl 
wells (Flow Labo ratories). After 24 h, the cultures we re cent ri-
fu ged (3000 rpm 5 min) and the supern atants were coll ected an d 
sterilized by filtration through a 20-,um filter (Schleicher and Schu l! , 
Germ an y). O ne aliquo t was tested fo r IL-2 acti vity and the rest 
was sto red at - 20°C. 
III/crlellkill 2 AcliJ/ i/), : The presence o f IL-2 in spl een cell super_ 
natants was assessed by its ability to sustain the g rowth o f an 
IL-2-depend ent cell lin e, C TLL-2 (g ift fro m Dr. Stro m) [201 . 
CTLL-2 (4 X 103) cells we re cultured in ro und- bo ttom ed Ini-
cro titer pl ates in a total vo lume o f 175 ,ul o f medium co ntainin g 
seri al dilutio ns of the sa mples to be tes ted . Fo ll owin g 24 h of 
culture 1 /-LC i ofl31-11th ymidin e (s p act 2 Ci/mM) w as added; after 
an additi onal 18 h o f incubation the incorpo ration o f[JH1th ymidi llc 
w as m easured in a scintill atio n counter. Results are ex pressed as 
IL-2 unit/ ml by reference to a standard curve gen erated llsing 
dilutio ns o f supe rn atant of Con A-stimulated DBA /2 spleen cell 
121] . 
Assay for IL-3 Activity 
Presence of IL-3 in th e epidermal cell culture supern atants w a 
tes ted by its ability to sustain the g rowth o f an I L-3-dependent 
cell lin e FDC P-2 (gift fro m Dr. M. D y) [22]. FDC P-2 (1 X 104) 
cells were cultured in 96- well mi cro titer plates in the presence or 
absen ce of serial diluti ons or th e sampl cs to be tested. The cultu re 
were in cubated 48 h at 37°C and w ere pul sed the las t 4 h w ith I 
,uC i o f [3H]th ymidinc per cell. The th ymidin e in corpo ration w a 
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Table I. Effect of Langerh ans Cell Dep letion on E LOIF 
Prod uction by Epid erm al Cell C ultures 
Day of Culture 
Supernatants 5 7 10 14 16 20 
Untreated ECC < I :8" I : 16 1: 64 1:512 I : 128 I: 16 
Langcrhans 1:8 1: 32 1:256 I : 512 1:256 1:8 
cel l-depicted 
ECC 
"Results ;lfC exp ressed as th e hig hest d iluti o n or the f CC S lI pCf ll ara m st ill acti ve 
in the rosette bioassay. 
measured in a scintil lation counter and results were expressed as 
cp m per culture. 
RESU LTS 
Keratinocytes Are the ELDIF-Producing Cells As previ-
o usly reported . optim al ELO IF acti v ity was fo und between da ys 
10-14 of ECC. correspond in g to the onset of supra basal kerati-
nocyte differentia tion [9J. In order to ru le out the ro le of Lang-
erhans cells in ELDIF prod uction , epide rm al cell suspensions were 
depleted of Lange rhans cells by pretrea tment w ith anti-HLA-DR 
monoclona l antibody and co mplement before cul ture. Table I 
shows that E LDIF act ivity ofECC supern ata nts was independent 
of the presence of Lan gerhans cells, indi ca tin g that keratin ocy tes 
are the E LD IF- producing cells within th e epidermis. 
A ctivity of Semipurified ELDIF Sem ipurifi ed E LD IF was 
p repared from a 14-day-old ECC supern ata nt, usin g a B ioGel P2 
co lumn. All the gel fi lt ration fra ctions were tested in the bioassay 
fo r T -cell di ffe rentiat in g activity. As show n in Fig 1, ELO IF 
acti vity eluted as a sing le peak in fraction s of M,. 500-900. T hese 
ac tive sa mp les as well as poo led fra ctions void ed ofE LOIF activ ity 
(titer >k) were subsequentl y used o r sto red at -2()°C. 
Biologic Characterization of ELDIF Alth o ugh E LDIF and 
ETAF are prod ucts of epiderm al cell s, on the basis o f their m o-
lecular weigh t they appea r to be differen t (ETAF: 15,000-25,000). 
Therefo re we sea rched for ETAF activity in o ur keratinocyte 
cu lture supern ata nts. Both crude ECC supern atant and partia ll y 
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Figure 1. Gel fi ltrat ion on Biogel 1'2 of crude ECC supernatants. O nc-
half milliliter of a 14-d.ly-old ECC supernata nt was applied on a 0.9 x 
60 cm column of BiogeJ P2 (Biorad), cqui li brated in a 0. 1 M phosphate 
buffer 100 111M NaCI containing 0.01 % NaN3 pH 7.4. A fl ow rate of 5 
ml/h was used and I-ml fra ctions werc collected. Cali bration of the col-
umn was performed with bacitrac in (M, = 1400) . thymu lin (M, = 850) , 
do mper idonc (M, = 465), phcnylbutazone (M,. = 312), and phenylalanine 
(M r = 160). All the fractions wcre tested at various di lutions in the 
bioassay fo r T-Iymphocytc differentiation acti vity. I ~es ults are expressed 
as the highes t active di lution responsib le for T-ce ll differentia tin g activity. 
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Table II. B io logic C hara cteriza tion of ELOIF 
ASSJY fo r: 
IL-I IL-2" IL-3 
Samples (cpm ± SE) (U/ ml) (cpm ± SE) 
ELD IF from 
Crude ECC supernatant 288 0 418 
Biogcl 1'2 fra ction 177 0 40 1 
IL- I" 11 ,989 NT NT 
IL-2' NT 1.0 NT 
IL-3" NT NT 14,545 
Mediulll alone 122 0 620 
A 14-day-o ld ECC s lI pernatant as well as a gel fi lt ration fract io n. both endowed 
with the same ELD IF 3ctivit y were rested (or (:1) IL- l-Iikc 3ctivity on m o use th y-
m ocy tes cu ltured in the presence of submi rogenic d oses o f PH A and (b) IL-2- and 
IL-3-like acti vit y o n IL-2-dcpcndcm CTLL-2 cell line and IL-3-dcpendent FDC I'2 
cell linc. rcs p(·cli vcly. 
·J Rcsults arc ex pressed as IL-2 units per 1111 by refe rence to :1 sta ndard curve obtained 
w ith C Oil A supernata n ts fro l11 nor lllal DBA /2 spleen cells. 
/o IL- I-colltainin g supernatant o f rnu ra l11 yi dipcpt idc-srimllb tcd adherent hUIll :lIl 
1l1 0 1l0Cy t cS . U sed at d ilmio n 1 : 8. 
' IL-2-containing supernata nt of Can A-st il11uloted DBA /2 splcen cells. 
JIL-3-co lltai llin g supcrn Hant frolll BALB/c m ouse-derived Ill ono lll ),clocyt ic cell 
lin e WE HI-3 (gift o f M . D y) . 
purified ELDIF did not exhibit IL-l-like acti vity as assessed by 
their in ability to enhance m ouse thy mocy te proliferation in the 
presence of PH A (Ta ble II ). T he absence ofa relatio nship between 
E LD IF and IL-l is further suppo rted by the observation that an 
IL-l-containin g supernatant of MOP (muramyl dipeptide)-stim-
ulated hum an monocytes did no t exhibit any acti v ity in the rosctte 
bioassay (da ta no t shown). In addition, E LOIF did not di spl ay 
any IL-2 o r IL-3 activity as shown by its in ability to susta in the 
g rowth of C TLL-2/ IL-2- and FOCP/ IL-3-depend ent cell lines 
(Tab le II). 
Effect ofELDIF on Lymphocyte Immune Functions In Vi-
tro Ex periments were condu cted usin g two sources of ELD IF: 
a 14-day-o ld crude ECC supernatant and a poo l of active gel 
filtration fract ions, both endowed w ith th e sam e ELOIF ac tiv ity 
(1 :256). N egative controls included a 5-day-old crude ECC su-
100 ® 100 ® t 
E 80 tr- - - .... __ / c.. 80 u I - .. 
I / 
I • 
0 ,/ / 
~ 60 60 I ..... c:: ,. • 0 
u 
'+-
0 40 40 
..... 
c:: 
Q) 
.. u 
~ 20 .---- 20 Q) r ~ 
/ 
• I 
1 ,27 1,81 1,243 1,729 1,27 1'81 1,243 1,729 
dilution 
Figure 2. Epiderm31 cel l-derived lymphocyte differentiating fac tor in-
hibition of mitogen responses of norll1al mouse spleen cells in vitro. 
Various di lutions of ECC supcrnatant (A) or semi purifi ed ELDIF (8) 
were added in mouse Iymphocytc cultures in thc presencc of mitogenic 
doses of either Con A (0 ), PHA (e), or LPS C.,). Lymphocyte prolif-
eration was assessed after 48 h of culture by thymidine incorporation. 
Results arc expressed as thc percentage of cpm in mi togen-stimulated 
cu ltu rcs wi th ECC supernatant (A) or sel1lipurified ELDIF (B) to that in 
mitogen-stilllulated culturcs without ELDIF or supernatant. 
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pernatant and a pool of ina ctive gel filtration fracti ons both voided 
o f ELD IF activity. C rude ECC supernatant ex hibited a dose-
dcpend en t inhibiti o n of m o use splenocyte pro liferati o n in re-
sponse to PI-lA , Con A , and LPS (Fig 2A). Similar rcsul ts we re 
o btained with partiall y purifi ed ELD IF (Fi g 28) . H owever, it 
should be no ted that the crude ECC supernatant is a m o re po tent 
inhibito r of mitogen responses thall th e gel fi ltration fra cti o n, 
sugges tin g th e presence in the crud e ECC supernata nt o f addi-
tion al suppressive m o lecules distin ct fro m ELD IF. This suppres-
s ive act ivity led to a co mp lete inhibitio n o f mitogeni c resp onses 
to all mitogens at a dilution of 1 :27 of cru de ELD IF. Th is effect 
was no t du e to toxicity sin ce the viab ility of lymphocytes wa s 
no t affected by ELD IF treat m ent. This inhibito ry effect appeared 
specifi c for E LDIF, sin ce b o th 5-da y-o ld ECC supernatant and 
the in ac tive co lumn fra ction used as contro ls were totall y inef-
fective (Fig 3). In contras t to the results obta in ed w ith mitogen-
stimulated lymphocy tes, ELD IF had no effect o n m o use spleen 
ly mph ocytes cultured in the absence of mitogen (Table II I). 
To ga in further insight into the m echanis m s of ELD IF-indu ced 
supp ression of lympho pro liferative responses, we in ves ti gated th e 
effect of ELD IF treatment on IL-2 production by Con A-stim-
ulated no rmal m o use spleen cells. W e observ ed a dramati c re-
duction in IL-2 productio n in supernatants of lymph ocy tes cul-
tured in the presence o f various diluti o ns of either semipurified 
ELD IF o r crude ECC supernatant (Fig 4). Contro l cultures per-
fo rm ed usin g ina ctive ECC supern atants o r in ac tive BioGeI P2 
column fract io ns ex hibited hi g h levels of IL-2, co mparable to 
those prod uced by lymphocy tes cu ltured with Con A alone (Fig 
4). These data sugges t that E LDIF inhibitio n o f Iymph o pro lifer-
atio n is mcdiated by its abi lity to prevent IL-2 sy nth csis. 
DISCUSSION 
Thc prescnt study cxa min es the immune pro perties o f partiall y 
purifi ed ELDIF, a soluble factor produ ced by cul tured hum an 
epidcrmal ccll s, and previously described fo r its th ymi c ho rm o nc-
lik e act ivity in thc rosette inhibitio n assay [9]. 
O ur data show that F LDIF is specifi ca ll y produ ced b y kerat-
inocy tes since elimination o f Langerhans cell s did no t alter its 
productio n . The recent dem o nstrati o n that epidermal cells are 
able to sy nth es ize IL-l-like fa cto rs (ETAF) [4,5] and IL-3-like 
factor 123] pro mpted us to determine the relati o nship between 
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Figure 3. Specifi city for ELDIF inhibition of Iymphopro li ferative re-
sponses . Thymidine incorporation during 48 h of culture of Con 
A-st imulated Ill ouse lymphocytes in the presence of medium alone 
(bar '1), ELDI F containing l4-day-old ECC supernatant (bill' 2) or gel 
fi lt ration colullln fra ction (ba r 4) , ELDIF-voided 5-day-old ECC super-
natant (bar J), or gel flitration colullln (btlr 5). All sa mpl es were used at 
final di lution 1:27. 
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Table III. Effect of Various Di lutio ns o f Se mipurified ELOIF 
o n the 13 H1ThYll1idin e In corpo rati o n by N orma l M o use 
·S pleen Cell s 
ELI)IF di lution 
1:3 
1: 27 
1 :243 
1:729 
Controls 
MediuI1l alone 
Con A 
IJHlTh Ylllidine Inco rporation (cpm)" 
929 
936 
85 1 
833 
1,0 10 
22,32 1 
"!'\H JTh Ylllidill c incorpor:1t ioll ill 48- 11 lymphocyte culture w itho tu mi togen. J\t'-
suits of 1 r~ prcscnt :1ti vc cxpc riIlH.:nr. 
ELD IF and kn ow n IYll1phokines. Our data indi ca ted th at it is 
distin ct fro m IL-I , IL-2, and IL-3 . When ELDIF was studied for 
its in vitro bio logic activity o n ly mph ocy te imll1une fun ction s, a 
stron g inhibitory effect of mitogen-indu ced IYll1ph o proliferati ve 
responses was observed . The ELDIF regulates both T- an d 
B-ccll-specifi c mitogeni c respo nses in a dose-dependent fas hi on. 
In additi o n , it is also ab le to preven t I L-2 produ ction by Con 
A-stimulated spleen cells . Since I L-2 (fo rmerly T-cell g rowth 
f.1cto r) is a ph ys iologic pro du ct of activated T ce lls, required for 
norm al T-l ymphocy te pro liferation 124], this latter findin g su g-
gcs ts th at the mechanism o f ELD IF suppress ive activity is m e-
diated by its effect o n IL-2 production. Th is hypo th es is ca n also 
account for the inhibito ry effect of ELD I F o n B-ccll pro li feration 
in the presence of LPS , sin ce ev id ence fo r th e presen ce of IL-2 
recepto rs has been reccntly repo rted o n certain B-cell subsets [25]. 
Furthermore, the mito geni c po tential o f LPS o n B cells is 
stren g th ened by the presence of I L-2 126]. C urrent in vestiga tions 
are in progress to determin e whether ELD IF is acting directly On 
IL-2 produ cin g T-cells or indirec tl y via th e stimulation of 
T-s uppressor cell s. We ca nnot cx clude the poss ibi lity th at the 
inhibito ry activ ity fo und in ELD IF-containin g sa mples is due to 
another facto r , co purified with ELD IF durin g the gel filtrati on 
procedure . In this res pect , arachidoni c ac id metabolites, and leu-
kotrien es in parti cular , are known to inhibit mitogen-ind uced 
T-ce ll pro liferatio n in humans [27]. H oweve r, it is unlikel y th at 
\cukotrienes are the inhibitory facto rs in o ur ECC sin ce unstim-
ula ted keratin ocytes produce o nly minute amounts of leuko-
trienes , w hi ch occurs within a few ho urs of culture 128J. Fur-
thermore , prclill1.inary experiments attempting purifi cation o f 
ELDI F b y reve rse-phase hi g h-performance liquid chro matog ra-
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Figure 4. E piderm al cell-derived lymph ocyte differentiati ng fa ctor in-
hib ition of lL-2 production by normal mouse spleen cells. Splenocytes 
were cultured with Con A in the presence of medium alone (b(lr 1) Or 
either a 14-day-old ECC superna tant (bar 2), 5-da y-old ECC supernatan t 
({)ar 3), semipurifi cd ELDIF (bar 4), or inactive gel fIltration column 
(bar 5). Lymphocyte culture supernatants were tested for IL-2 by their 
abil ity to sustain the growth of the CTLL-2 cell line. Data obtained with 
samples uscd at di lution I :27 are prescnted . 
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phy showed that the column fra ction s positi ve in the rosette bioJs-
say were also endowed w ith ly mph ocyte inhibi to ry fun ctions (L. 
Castine l, J. F. Ni co las , unpublish ed dat:!) suggestin g th:!t ELDIF 
was respo nsible fo r both 3Ctivitics. Actu all y it is not unusu31 to 
fin d a molecule endowed w ith T-cel l differentiatin g and sup-
pressive function s. In this rega rd , thymic ho rm ones (a nd es pe-
cia ll y FTS) whi ch indu ce th eta 3ntigen express ion on immature 
T cells can also exert imillunoregul atory activities via the indu c-
tion of T suppresso r cell s [29 1, w hich account for pro longa ti on 
of skin all ograft survival PO]. 
With the exceptio n of ETAF 14 1, the effect of ep idermal cell 
produ cts on ly mphocy te function s is poorl y docum ented. It is 
interes tin g to note th:!t ET AF and ELD I F, althou g h ineffective 
on the proliferatio n of un stilllulated lymp hocytes , exerts the op-
posite reg ulatory activity o n mitogen-stimulated lymph ocyte re-
sponses an d IL-2 producti on . The ETAF leads to an aug mentation 
of IL-2 production b y Con A-stimulated spleen cell s [4J, w hile 
ELDIF has a suppressive effect. Alth oug h distin ct from ETAF 
on the basis of its m olecular weight and fun ction al pro perti es, 
one ca nn ot conclu de from these data w hether ELDI F is a distin ct 
entity or a deg radation product of ETAF th at has lost its IL-l-
like activ ity . 
Th is report is the first dem onstrat ion of the presence in norm al 
hu m an ECC performed in serum-free conditions of a soluble 
fac tor displayin g lymphocyte differentiating and regulatin g ac-
tiv ities. The ELDIF w as previous ly shown to be unrelated to the 
well-known thymi c ho rm o ne thymu lin , thymopo ietin, and thy-
11l0sin 0'1 [9 ]. Recentl y, Rubenfeld et al 18] repo rted that COClll-
tiva tion of sy ngeneic o r all ogeni c epiderm al cells w ith lymph oid 
cells was responsible for the induction ofTdT, a mark er of ea rl y 
ly mph ocy te differentiation , on previo us ly TdT-nega tive ce lls. 
Si milar d:lta obtain ed w ith ECC supern atants indi ca ted the ex-
istence of a solubl e T-cell differentiating fa ctor produced by epi-
derm al cel ls. H oweve r, it appears fr0111 kinetic studies that this 
facto r found in the first 3 da ys of ECC is distin ct fro m ELDIF 
w hi ch is produced m ax imall y arou nd day 14 and is negative be-
fore da y 5 of cultures 19]. Of major interest is the fa ct that epi-
dermal cells from patients with mycos is fungoides (MF) prod uce 
in vitro T - cell differentiatin g activ ity [311 which is also found in 
their serum but not in supern ata nts from normal ECC, no r in 
no rm al human serum [32]. This activity was described as a FTS-
like reactivity w hen tested with the same bioassay that we used 
fo r E LDIF 131]. " MF facto r" is different from th e well-known 
thymi c ho rm one sin ce it also displa ys 13 cell-indu cin g activity and 
does not decline w ith age . Altho ug h the epiderm al orig in of MF 
fac tor found in th e serum of cutaneous T -cell lym ph o mas was 
not dem onstrated, its relationship to ELDIF remains open to 
specul ation. It is possible, however, that in norm al ph ys io logic 
conditions, th e con centration o f such fa ctors in the se rum is under 
the limit of detection and that their produ ction is enh anced as a 
conseq uence of m alig nancy . In any case, the precise biochem ica l 
na ture of ELD IF and its in vivo releva nce remains to be clarified. 
O ur data showin g that ELD IF, w hi ch displa ys T-Iymphocyte 
ma turation activity, also ex hibits potent suppress io n of lympho-
cy te proliferati ve responses, su ggest th at the epider mi s produces 
so luble facto rs w hi ch ma y playa cru cial role in the reg ulati on of 
cuta neo us inA aml11atory reactions . 
We are <Qrale}ili «l Dr. irllla G(~/i }iJl' crilical disCl/ssiolls a//(I hclp}itl IIdvice ill 
revicl/lillg Ihis IIIt1IlIl SCripl. We arc illdeblcd to Michel Dy a//(I C II(1I1II1 I DlIlIl(1is 
for Ilreir help ill , respcct ive/y, Ihe IL-J a//{I IL- l lIssays. We lIIish 10 Ih""i: Ivl. 
C. Gag ll ert1lll j or I,er expert ,ec/Illical ass islall ce. 
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